Bionime Balance Sheet Health

Financial Health criteria checks 0/6

Bionime has a total shareholder equity of NT$1.9B and total debt of NT$2.9B, which brings its debt-to-equity ratio to 158.8%. Its total assets and total liabilities are NT$5.6B and NT$3.7B respectively.

Key information

158.8%

Debt to equity ratio

NT$2.94b

Debt

Interest coverage ration/a
CashNT$387.35m
EquityNT$1.85b
Total liabilitiesNT$3.70b
Total assetsNT$5.55b

Recent financial health updates

Recent updates

Bionime (TWSE:4737) Is Reducing Its Dividend To NT$2

Jul 22
Bionime (TWSE:4737) Is Reducing Its Dividend To NT$2

Bionime (TWSE:4737) Will Pay A Smaller Dividend Than Last Year

Jul 01
Bionime (TWSE:4737) Will Pay A Smaller Dividend Than Last Year

These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong

Apr 29
These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong

Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?

Mar 23
Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?

Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?

Mar 05
Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?

Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?

Feb 15
Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?

Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet

Feb 01
Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet

How Has Bionime (TPE:4737) Allocated Its Capital?

Jan 19
How Has Bionime (TPE:4737) Allocated Its Capital?

A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE

Jan 06
A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE

A Look At The Fair Value Of Bionime Corporation (TPE:4737)

Dec 22
A Look At The Fair Value Of Bionime Corporation (TPE:4737)

Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend

Dec 09
Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend

Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment

Nov 24
Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment

Financial Position Analysis

Short Term Liabilities: 4737's short term assets (NT$1.6B) do not cover its short term liabilities (NT$2.0B).

Long Term Liabilities: 4737's short term assets (NT$1.6B) do not cover its long term liabilities (NT$1.7B).


Debt to Equity History and Analysis

Debt Level: 4737's net debt to equity ratio (137.8%) is considered high.

Reducing Debt: 4737's debt to equity ratio has increased from 101.8% to 158.8% over the past 5 years.

Debt Coverage: 4737's debt is not well covered by operating cash flow (6.3%).

Interest Coverage: Insufficient data to determine if 4737's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 12:18
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bionime Corporation is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ryan LiuIBTS Investment Consulting Co., Ltd.
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.
Hsiu Chi LinMasterlink Securities Corp.